B-CLL cells are capable of synthesis and secretion of both pro- and anti-angiogenic molecules
- 1 May 2002
- journal article
- research article
- Published by Springer Nature in Leukemia
- Vol. 16 (5) , 911-919
- https://doi.org/10.1038/sj.leu.2402467
Abstract
Leukemia is one of the leading journals in hematology and oncology. It is published monthly and covers all aspects of the research and treatment of leukemia and allied diseases. Studies of normal hemopoiesis are covered because of their comparative relevance.Keywords
This publication has 61 references indexed in Scilit:
- Angiogenesis in acute promyelocytic leukemia: induction by vascular endothelial growth factor and inhibition by all-trans retinoic acidBlood, 2001
- Elevated vascular endothelial growth factor (VEGF) serum levels in idiopathic myelofibrosisLeukemia, 2001
- The application of an antiangiogenic gene (thrombospondin-1) in the treatment of human prostate cancer xenograftsCancer Gene Therapy, 2000
- Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migrationJournal of Clinical Investigation, 2000
- Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors.Journal of Clinical Investigation, 1998
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisPublished by Elsevier ,1996
- Interleukin 6 Induces the Expression of Vascular Endothelial Growth FactorJournal of Biological Chemistry, 1996
- Protein Tyrosine Kinases Expressed in Glomeruli and Cultured Glomerular Cells: Flt-1 and VEGF Expression in Renal Mesangial CellsBiochemical and Biophysical Research Communications, 1995
- Human Melanoma Cells but Not Normal Melanocytes Express Vascular Endothelial Growth Factor ReceptorsBiochemical and Biophysical Research Communications, 1993
- Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesisNature, 1992